Phase II trial of dacarbazine, mitomycin, doxorubicin, and cisplatin with sargramostim in uterine leiomyosarcoma: a Gynecologic Oncology Group study (Q33367537)
scientific article
Language:
Current Data About Phase II trial of dacarbazine, mitomycin, doxorubicin, and cisplatin with sargramostim in uterine leiomyosarcoma: a Gynecologic Oncology Group study
(P31) (Q13442814)
(P248)
(P698) 16051328
(P813) Wednesday, July 26, 2017

(P304) 339-342
(P248)
(P698) 16051328
(P813) Wednesday, July 26, 2017

(P407) (Q1860)

(P433) 2
(P248)
(P698) 16051328
(P813) Wednesday, July 26, 2017

(P478) 99
(P248)
(P698) 16051328
(P813) Wednesday, July 26, 2017

(P577) Tuesday, July 26, 2005
(P248)
(P698) 16051328
(P813) Wednesday, July 26, 2017

(P921) (Q42824440)

(Q3950557)

(Q18936)
(P887)

(Q5625186)
(P887)

(Q1504713)
(P887)

(Q416975)
(P887)

(Q412415)
(P887)

(P1433) (Q5625182)
(P248)
(P698) 16051328
(P813) Wednesday, July 26, 2017

(P1476) "Phase II trial of dacarbazine, mitomycin, doxorubicin, and cisplatin with sargramostim in uterine leiomyosarcoma: a Gynecologic Oncology Group study" (language: en)
(P248)
(P698) 16051328
(P813) Wednesday, July 26, 2017

(P2093) Harry J Long
(P1545) 1
(P248)
(P698) 16051328
(P813) Wednesday, July 26, 2017

John A Blessing
(P1545) 2
(P248)
(P698) 16051328
(P813) Wednesday, July 26, 2017

Joel Sorosky
(P1545) 3
(P248)
(P698) 16051328
(P813) Wednesday, July 26, 2017

(P2860) (Q42247369)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.002
(P813) Thursday, January 7, 2021

(Q68043717)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.002
(P813) Thursday, January 7, 2021

(Q33362563)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.002
(P813) Thursday, January 7, 2021

(Q71615046)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.002
(P813) Thursday, January 7, 2021

(Q54340843)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.002
(P813) Thursday, January 7, 2021

(Q34621999)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.002
(P813) Thursday, January 7, 2021

(Q33342752)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.002
(P813) Thursday, January 7, 2021

(Q44536416)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.002
(P813) Thursday, January 7, 2021

(Q33355632)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.002
(P813) Thursday, January 7, 2021

(Q33343936)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.002
(P813) Thursday, January 7, 2021

other details
description scientific article

External Links
(P356) 10.1016/J.YGYNO.2005.06.002
(P698) 16051328